vimarsana.com

Page 25 - பெர்கோஃபர் மருத்துவ ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Frontiers | Barriers and Considerations for Diagnosing Rare Diseases in Indigenous Populations

2National Centre for Indigenous Genomics, Australian National University, Canberra, ACT, Australia 3Department of Pharmacology, Dalhousie University, Halifax, NS, Canada 4Precision Medicine, Platform on Shaping the Future of Health and Healthcare, World Economic Forum, San Francisco, CA, United States 5Institute of Genetics, Canadian Institutes of Health Research, Government of Canada, Ottawa, ON, Canada 6Human Metabolomics, North-West University, Potchefstroom, South Africa 7Facultad de Medicina, Center for Genetics and Genomics, Clinica Alemana Universidad del Desarrollo, Santiago, Chile 8Institute of Health Management, Southern Medical University, Guangdong, China 9KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa 10Rare Diseases South Africa, Johannesburg, South Africa

Novel discovery provides hope for early detection of serious Covid-19 cases

Novel discovery provides hope for early detection of serious Covid-19 cases ANI | Updated: Dec 12, 2020 14:04 IST Brisbane [Australia], December 12 (ANI): A new way of testing whether or not Covid-19 patients immune systems are gearing up to fight the virus that causes the deadly disease has been developed by Australian researchers. The researchers from QIMR Berghofer Medical Research Institute hope the discovery could be used to identify early on which patients immune systems are not responding appropriately, and who might be at higher risk of becoming seriously unwell. The prototype test detects high levels of two key chemical signals that are produced by T cells when they recognise SARS-CoV-2-infected cells and start to fight the infection. SARS-CoV-2 is a virus that causes COVID-19.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.